Related Experiment Video
Updated: Jan 8, 2026

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
Published on: July 22, 2021
Prevalence of Arthritis-Attributable Activity Limitations - United States, 2023
Ellen W Stowe1, Daniel K White2, Michael A Boring3
1Centers for Disease Control and Prevention, Atlanta, Georgia.
Objective:
The objectives of this study were (1) to estimate the 2023 prevalence of arthritis-attributable activity limitations (AAAL) among US adults with arthritis overall and by selected sociodemographic and health characteristics and (2) to assess progress toward the Healthy People 2030 objective to reduce AAAL by describing the change in AAAL prevalence from 2019 to 2023.
Methods:
Cross-sectional data from the 2019 and 2023 National Health Interview Survey were used. Unadjusted and age-standardized prevalences of AAAL in 2023 were estimated overall and by sociodemographic and health characteristics among US adults who reported having doctor-diagnosed arthritis. Differences in the prevalence of AAAL by sociodemographic and health characteristics were assessed using t-tests. The overall unadjusted and age-standardized prevalences of AAAL in 2019 were estimated and tested against 2023 estimates for differences by survey year (2019 and 2023).
Results:
During 2023, an estimated 24.8 million adults with arthritis reported having an activity limitation (age-adjusted prevalence, 47.8%; 95% confidence interval [CI], 45.0%-50.7%). There were significant differences in age-adjusted AAAL prevalence by sociodemographic and health characteristics. Although there was a decline in the estimated age-adjusted prevalence of AAAL from 2019 (49.2%; 95% CI, 46.7%-51.6%) to 2023, this change was not statistically significant.
Conclusion:
About half of US adults with doctor-diagnosed arthritis report activity limitations due to arthritis, and the Healthy People 2030 objective for an AAAL prevalence of 46.8% has not been met. Organizations, working individually or as partners, to implement arthritis-appropriate evidence-based interventions could contribute to achieving the Healthy People 2030 goal of reducing AAAL among US adults with arthritis.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
The JAK-STAT Signaling Pathway
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
Peripheral Artery Disease III: Interprofessional Care

